Versant Ventures related stories
All articles and analysis
CardiAQ Valve Technologies Wraps Up $37.3M RoundCardiAQ Valve Technologies Inc., a medical device company developing technologies for “percutaneous mitral heart valve replacement,” has raised $37.3 million in a second round of funding. OrbiMed led the round and was joined by Versant Ventures, Advent Life Sciences and existing investors. The latest funding incorporates conversion of a 2011 bridge financing, the company said in a press release.
Booms & Busts for VCs in Q4 IPOsForget Facebook’s face-plant: its enterprise service firms and semiconductor companies that have institutional investors’ ears at IPO time, now. 2012’s fourth quarter showcased some successful IPOs, so far. PeHUB tracks the latest companies to try to mint VCs millions on public markets with today's slideshow.
- In Praise of Drug Megafunds
Researchers in the financial engineering lab at M.I.T. think they've struck on a solution that would allow investors to lower their risk, access new capital sources, and create more diverse portfolios while also giving a major shot in the arm to early-stage drug development.
- Q2 Contains Little Good News for Life Sci Startups
Sure, they've been racking up some nice exits--but venture capitalists in the life sciences space haven't been putting too much capital to work in Q2-'12, and this could be cause for concern with some hot startups.
- Virtual Biotechs a Real Business for VCs
With some VCs retreating from life sciences, investors are lauding the growing popularity of virtual biotechs as a capital efficient way to get the most bang for their buck
- Life Sci VCs Versant Plot Fund V
Life sciences and biotech VCs don't have it easy--and Versant Ventures, with a lengthy track record, is out to buck the trend and raise a big new fund, peHUB has learned.